Skip to main content
LONA
NASDAQ Life Sciences

LeonaBio Discloses Highly Dilutive Private Placement, More Than Doubling Shares Outstanding

Analysis by Wiseek.ai
Sentiment info
Negative
Importance info
9
Price
$6.01
Mkt Cap
$56.733M
52W Low
$3.6
52W High
$59
Market data snapshot near publication time

summarizeSummary

This Schedule 13D/A filing by Perceptive Advisors reveals a substantial private placement by LeonaBio, Inc., where 5,356,547 new shares were issued. This issuance represents a 135% increase in the company's outstanding shares, moving from approximately 3.9 million to 9.3 million shares. While the capital raised from this offering provides a financial runway, the extreme dilution is a significant negative for current shareholders, as it substantially reduces the per-share value of their holdings. Perceptive Advisors' ownership percentage has been adjusted to 19.99% as a result of this increased share count, not due to any sale of their holdings.


check_boxKey Events

  • Significant Share Dilution

    LeonaBio issued 5,356,547 new shares in a private placement, increasing total outstanding shares by 135% to 9,300,434.

  • Major Capital Raise

    The private placement provided substantial capital to the company, though at the cost of significant dilution for existing shareholders.

  • Perceptive Advisors' Stake Adjusted

    Perceptive Advisors' beneficial ownership percentage was adjusted to 19.99% due to the increased share count, not from any sale of their shares.


auto_awesomeAnalysis

This Schedule 13D/A filing by Perceptive Advisors reveals a substantial private placement by LeonaBio, Inc., where 5,356,547 new shares were issued. This issuance represents a 135% increase in the company's outstanding shares, moving from approximately 3.9 million to 9.3 million shares. While the capital raised from this offering provides a financial runway, the extreme dilution is a significant negative for current shareholders, as it substantially reduces the per-share value of their holdings. Perceptive Advisors' ownership percentage has been adjusted to 19.99% as a result of this increased share count, not due to any sale of their holdings.

この提出時点で、LONAは$6.01で取引されており、市場はNASDAQ、セクターはLife Sciences、時価総額は約$5673.3万でした。 52週の取引レンジは$3.60から$59.00でした。 この提出書類はネガティブの市場センチメント、重要度スコア9/10と評価されました。

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed LONA - Latest Insights

LONA
Apr 01, 2026, 9:30 PM EDT
Filing Type: 424B3
Importance Score:
8
LONA
Apr 01, 2026, 9:30 PM EDT
Filing Type: 424B3
Importance Score:
7
LONA
Mar 31, 2026, 5:07 PM EDT
Filing Type: S-1/A
Importance Score:
8
LONA
Mar 31, 2026, 4:59 PM EDT
Filing Type: S-1/A
Importance Score:
8
LONA
Mar 31, 2026, 4:11 PM EDT
Filing Type: 10-K
Importance Score:
9
LONA
Mar 31, 2026, 2:20 PM EDT
Filing Type: 8-K/A
Importance Score:
8
LONA
Mar 26, 2026, 5:10 PM EDT
Filing Type: 8-K
Importance Score:
9
LONA
Mar 26, 2026, 5:10 PM EDT
Source: GlobeNewswire
Importance Score:
9
LONA
Mar 19, 2026, 4:50 PM EDT
Filing Type: 8-K
Importance Score:
9
LONA
Feb 23, 2026, 4:05 PM EST
Filing Type: DEF 14A
Importance Score:
9